SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Panacea Biotec

BSE: 531349|NSE: PANACEABIO|ISIN: INE922B01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 26, 15:41
107.80
-1.2 (-1.1%)
VOLUME 1,782
LIVE
NSE
Aug 26, 15:57
107.20
-2.3 (-2.1%)
VOLUME 17,416
Announcements on Panacea Biotec

13th-Aug-2016 12:00Source: BSE

Panacea Biotec- Fixes Book Closure for AGM

Panacea Biotec Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2016 to September 28, 2016 (both days inclusive) for the pu...

12th-Aug-2016 16:44Source: BSE

Panacea Biotec- Standalone Financial Results, Limited Review Report for June 30, 2016

Panacea Biotec Ltd has informed BSE about :

1. Standalone Financial Results for the period ended June 30, 2016

2. Standalone Limited Review for the period ended June 30, 2016

2nd-Aug-2016 17:12Source: BSE

Panacea Biotec- Credit Rating

Panacea Biotec Ltd has informed BSE regarding "Credit Rating for Long Term Bank Facilities of Rs.959.55 cr. and Short Term Bank Facilities of Rs. 61.97 cr."

28th-Jul-2016 16:18Source: BSE

Panacea Biotec- Board Meeting Intimation for Results & Closure of Trading Window

Panacea Biotec Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on August 12, 2016, inter alia, to consider and approve the Unaudited Financial Resu...

27th-Jul-2016 16:11Source: BSE

Panacea Biotec- Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011

Sunanda Jain has submitted to BSE, vide letter dated July 27, 2016, a copy of disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a) (i)of SEBI (Substantial Acquisition ...

27th-Jul-2016 15:48Source: NSE

Panacea Biotec Limited

Sunanda Jain has submitted to the Exchange vide letter dated July 27, 2016 a copy of disclosure under Regulation 10(7) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

21st-Jul-2016 11:41Source: BSE

Panacea Biotec- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

Panacea Biotec Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing O...

20th-Jul-2016 15:49Source: BSE

Panacea Biotec- Shareholding for the Period Ended June 30, 2016

Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly

11th-Jul-2016 13:04Source: BSE

Panacea Biotec- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

Sunanda Jain has submitted the disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

11th-Jul-2016 12:57Source: BSE

Panacea Biotec- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Sunanda Jain has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

1 2 3 4 5 Next >>
Quick Links for Panacea Biotec
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.